Should life-saving medicines be patentable if only the wealthy can afford them? Who should control Robot-ready plants controlled by patented technology that trained on sovereign genetic resources? Can we describe gene sequences as inventions in the same way as we describe computer programs? Why do pharmaceutical companies rely so much on patent protection? How should the pandemic treaty address patentability of pathogens? LL435E will enable you to have a doctrinally sound and critical approach to questions like these.
This module aims to provide a sound grounding in the legal protection of inventions and the technology-specific application of doctrine while exploring unprecedented and urgent challenges to justice raised by the control of technologies by patent holders. A critical objective of the course is to examine patent law as a site of struggle over knowledge and therefore power by interrogating how patent systems shape access to medicines, food security, and technological development. Based on UK and European patent law the course will consider technology-specific legal doctrine, patent prosecution and institutional features, and industry specific comparative perspectives. Through case studies spanning biotechnology, artificial intelligence, synthetic biology, and biodiversity students will gain technical competence in patent law and the critical frameworks needed to evaluate whether patent law serves innovation or extraction, public interest or private in specific instances. The course will cover patentability and exclusions to patentability; direct and indirect infringement and defences such as research use will not ordinarily be covered. A scientific background is not necessary, tolerance for legally relevant descriptions of science and an aptitude for interdisciplinary understandings of technology is very welcome.
Some indicative lecture topics and case studies are as follows:
1. The Innovation Bargain and the Justification Problem
a. Covid-19 vaccine equity
b. Historic evolution of patents as rights.
2. What Counts as ‘New and Inventive’ 
a. The politics of priority and invention
b. Traditional knowledge 
c. New and inventive in the pharmaceutical sector
3. Everything you Cannot Patent (Or can you?) 
a. Genomic inventions: Owning the fabric of life
b. Computer-implemented claims
c. Artificial intelligence and generative biology
4. Reading Between the Lines: Claims, Construction, and Strategic Drafting
a. Understanding the property parameters of patents
b. Patent offices as special interest actors
5. TRIPS and Its Discontents
a. Technology transfer and patents
b. Biodiversity, sovereign rights and patents
c. Patent law and distributive justice
Lecturer: Dr Siva Thambisetty
Module Code: LL435E